Striking changes in anxiety in Huntington's disease transgenic mice.
Huntington's disease transgenic mice were tested in the elevated plus-maze test of anxiety at 6, 8, 10 and 12 weeks of age. At all ages, they showed significant and striking increases in the percentages of open arm entries and time spent on the open arms, compared with their normal littermates, indicating reduced anxiety. These increases were not secondary to a non-specific stimulant effect, since the transgenic mice made fewer closed arm entries, significantly so from 10 weeks of age. The mice were also tested in the holeboard, which provides measures of locomotor activity and directed exploration. From 8 weeks of age, the Huntington's mice were significantly less active than their normal littermates and made fewer exploratory head-dips. The increased open arm activity in the elevated plus-maze cannot therefore be secondary to increased exploration in the transgenic mice. In order to determine whether the reduced anxiety was due to differences in benzodiazepine receptor function, the mice were challenged with the benzodiazepine receptor antagonist, flumazenil. The results indicated that some of the reduced anxiety could be attributed to the presence of an endogenous anxiolytic ligand.
File
S E
SE
Department of Psychopharmacology, UMDS, Guy's Hospital, London SE1 9RT, UK. s.file@umds.ac.uk
Mahal
A
A
Mangiarini
L
L
Bates
G P
GP
D000818:Animals; D001007:Anxiety / Q000523:psychology*; D005106:Exploratory Behavior / Q000502:physiology; D005260:Female; D005442:Flumazenil / Q000494:pharmacology; D006816:Huntington Disease / Q000235:genetics / Q000523:psychology*; D018782:Maze Learning / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic / Q000235:genetics; D013045:Species Specificity
D005442:Flumazenil